Kahn Brothers Group recent buys & sells (2014 Q3)
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group Portfolio Changes
Purchase & sale details
- Portfolio value:
- $614.81M (-$73M)
- Previous value:
- $687.33M
- # of changes:
- 33
- New positions:
- 1
- Reported for:
- 30 Sep 2014 (Q3)
- Latest filing date:
- 06 Nov 2014
Kahn Brothers Group has disclosed a total of 33 changes to the portfolio in the (2014 Q3) SEC report(s): increased the number of shares of 4, bought 1 totally new and decreased the number of shares of 28 position(s).
What stocks did Kahn Brothers Group buy in 2014 Q3?
In the 2014 Q3 report(s) the following changes have been made to the top investments: (MRK) Merck & Company Inc (reduced shares -0.97%), (C) Citigroup Inc (reduced shares -11.30%), (PFE) Pfizer Inc (reduced shares -6.56%), (FLG) Flagstar Bank, National Association (reduced shares -5.38%) and (NYT) New York Times Company (reduced shares -1.87%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".